In the last few weeks, we’ve talked a lot about “hated” dividends set to soar as mainstream investors get it wrong on Trump 2.0.
Last week, we covered utility stocks, “bond proxies” that look great here, and a 7.6%-yielding utility fund to buy now.
This week we’re shifting to another despised corner of the market, again thanks to the new administration—healthcare. But our play isn’t some middling payer, like 3%-yielding Johnson & Johnson (JNJ).
A 13% Dividend That Grows
Instead, we’re going to drop a “1” in front of that “3” and buy a 13%-yielding healthcare closed-end fund (CEF).… Read more
Recent Comments